Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Efficacy of Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

NCT07526454 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07526454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07526454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Efficacy of Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2025
Completion date
February 1, 2026
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electroconvulsive therapy, intravenous ketamine, major depressive disorder, treatment-resistant